News + Filings Transactions
|
Caissa Capital Management ltd.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/09/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 5k | $4.14 | $20.9k | See Footnote (1) | 06/07/2023 |
| 06/08/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 6.4k | $3.93 | $25.1k | See Footnote (1) | 06/07/2023 |
| 06/07/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 3k | $3.49 | $10.4k | See Footnote (1) | 06/07/2023 |
| 05/31/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 844 | $2.87 | $2.4k | See Footnote (1) | 05/31/2023 |
| 05/30/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common stock | 671 | $2.87 | $1.9k | See Footnote (1) | 05/25/2023 |
| 05/25/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common stock | 2k | $2.77 | $5.5k | See Footnote (1) | 05/25/2023 |
| 05/24/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 3.5k | $3.01 | $10.5k | See Footnote (1) | 05/24/2023 |
| 05/24/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 5.5k | $2.96 | $16.3k | See Footnote (1) | 05/24/2023 |
| 05/16/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common stock | 379 | $2.75 | $1k | See Footnote (1) | 05/12/2023 |
| 05/15/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common stock | 1.7k | $2.55 | $4.4k | See Footnote (1) | 05/12/2023 |
| 05/12/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common stock | 2.3k | $2.45 | $5.6k | See Footnote (1) | 05/12/2023 |
| 05/08/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 5k | $2.62 | $13.1k | See Footnote (1) | 05/04/2023 |
| 05/05/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 5k | $2.88 | $14.4k | See Footnote (1) | 05/04/2023 |
| 05/04/2023 | Avalo Therapeutics, Inc. | CERC | Purchase | Common Stock | 15k | $2.79 | $41.9k | See Footnote (1) | 05/04/2023 |
|